Kaliumlosartan/Hydrochloorthiazide Sandoz

Losartan potassium, the active ingredient in Kaliumlosartan/Hydrochloorthiazide Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It lowers elevated blood pressure in adult patients with hypertension. GNH USA supplies Kaliumlosartan/Hydrochloorthiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Kaliumlosartan/Hydrochloorthiazide Sandoz combines an ARB and a thiazide diuretic to manage conditions related to high blood pressure. - Hypertension: reduces systolic and diastolic pressure in essential hypertension. - Left ventricular hypertrophy: helps decrease cardiac workload associated with prolonged hypertension. - Diabetic nephropathy with proteinuria: may slow renal function decline when used as part of a comprehensive treatment plan.

Common side effects are usually mild and transient.

Common Side Effects: - Dizziness: feeling light‑headed, especially after the first doses. - Headache: mild to moderate intensity. - Fatigue: general tiredness or lack of energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: particularly low potassium levels. - Mild gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe dehydration: marked fluid loss requiring medical attention. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: dangerously high potassium levels. - Anaphylactic reaction: severe allergic response with rash, swelling, or breathing difficulty. - Blood dyscrasias: rare blood cell abnormalities such as agranulocytosis.

Before initiating therapy, several safety considerations are recommended. - Blood pressure monitoring: ensure target levels are achieved without excessive drop. - Renal function assessment: check serum creatinine and eGFR regularly. - Electrolyte surveillance: monitor potassium and sodium levels, especially in patients on other diuretics. - Pregnancy caution: avoid use in pregnancy due to fetal toxicity risk. - Elderly dosing: start at lower dose and titrate cautiously. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kaliumlosartan/Hydrochloorthiazide Sandoz may interact with several medicines.

Major Interactions (Avoid): - Aliskiren in diabetic patients: combined use can increase renal adverse events. - Potassium supplements or potassium‑sparing diuretics: risk of hyperkalemia. - NSAIDs (e.g., ibuprofen): may reduce antihypertensive efficacy and impair renal function. - Lithium: increased lithium levels and toxicity. - Dual thiazide therapy: heightened risk of electrolyte disturbances.

Moderate Interactions (Monitor Closely): - CYP2C9 inhibitors (e.g., fluconazole): may raise losartan plasma concentrations. - Other antihypertensives: additive blood pressure lowering effect. - Antidiabetic agents: potential for enhanced hypoglycemia. - Antacids containing aluminum or magnesium: may affect absorption of losartan. - Loop diuretics: monitor for excessive diuresis and electrolyte loss.